Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) to treat several forms of bladder cancer, which is the most common type of urothelial cancer. It is approved in combination with enfortumab…
Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of bladder cancer. It is prescribed to treat advanced or metastatic (spreading) urothelial cancer, nonmuscle invasive…
read more